Asset
PL-3994
PALATIN TECHNOLOGIES INC. COMMON STOCK
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01304628 | phase2 | withdrawn | — | — | Palatin Technologies, Inc | Cross-Over Study of Subcutaneous Study Drug for the Treatment of Patients With Mild to Moderate Asthma |
FDA applications (0)
This company has no applications containing this asset.